Username:
Forgot username and/or password?
Password:
You are here: Home > Women's Health > Breast Cancer Genetic Test

Women's Health
Breast Cancer Genetic Test


•  Breast Cancer Risk Factors
•  Breast Self-Exam
Deepi Brar
CONSUMER HEALTH INTERACTIVE

Below:
 • What is the breast cancer genetic test?
 • Should I consider getting tested?
 • What will the test tell me?
 • How do I get tested?
 • Does a negative result mean I'm free and clear?
 • What can I do if it turns out I do have a mutation?
 • How can I find a qualified genetic counselor?


Inherited gene mutations account for a small minority of breast cancer cases. Even in families in which several women have the disease, researchers say genetic defects are uncommon. How, then, do you determine if a genetic test is a good idea for you?

What is the breast cancer genetic test?

This test looks for mutations in two genes, BRCA1 and BRCA2 (BR for breast and CA for cancer), that may indicate a substantially higher risk for getting breast or ovarian cancer . (Only 5 to 10 percent of all breast cancers diagnosed are associated with a known BRCA genetic mutation.) You're born with two copies of each gene. If you've inherited a mutation in one copy, lots of things can go wrong. Usually, its healthy partner can handle the workload. But if anything happens to the second copy -- you're exposed to a carcinogen, say, or you simply undergo the ravages of age -- the mistakes can multiply in each new generation of cells and lead to cancer.

Should I consider getting tested?

This is something you'll want to think through carefully. Don't rely on promotional materials to make your decision; companies and labs often overstate the value and accuracy of the tests. Some literature, for example, claims that breast cancer targets Ashkenazi Jewish women in particular. But although Ashkenazi Jewish women may be likelier to inherit certain mutations, only seven percent of breast cancers in Ashkenazi women are caused by BRCA1 and BRCA2.

Still, recent studies have shown that Ashkenazi Jewish women with BRCA1 and BRCA2 mutations are at much higher risk for breast cancer than the general population. For example, the New York Breast Cancer Study estimated the risk of breast cancer by age 70 to be 69 percent for BRCA 1 carriers and 71 percent for BRCA2 carriers, compared to 12 percent for the general population.

If you're considering having the test, the first thing you should do is make an appointment with a genetic counselor to get impartial, informed advice. You may also want to involve your primary care doctor in your decision or consult a breast surgeon or oncologist.

In 1999 the American College of Medical Genetics developed guidelines for assessment, counseling, and genetic testing for breast and ovarian cancer. You may be a candidate for testing if three or more first- or second-degree relatives were diagnosed with breast cancer. You may also consider testing if you have less than three affected relatives and any of the following applies:

You or the affected relative were diagnosed at an early age, especially before age 45
A family member has a detectable mutation
There is a family history of at least one case of ovarian cancer at any age, in addition to one or more cases of breast cancer on the same side of the family at any age
You or a family member has cancer in both breasts or multiple primary breast cancers
There is breast cancer in a male relative
Your ethnic background puts you at increased risk, and you have at least one relative with breast or ovarian cancer.

Researchers also believe that the test would be more helpful to you if a relative with breast or ovarian cancer also agrees to be tested, so that analysts can test you for the same mutation. If you already have had breast cancer yourself, you may want to be tested for the benefit of all the other members of your family, including your children.

Finally, consider whether the advantage of knowing your risk outweighs the potential trouble that the information can bring. A negative result does not mean that you won't get cancer, or even that you're not at high risk, so you'll still need to be vigilant about breast exams and mammograms.

And since there aren't any foolproof ways to avoid getting breast cancer, think about whether a positive result may cause you undue anxiety. Studies have shown that testing positive for a known breast cancer mutation can incite anxiety levels comparable to those of women who've actually been diagnosed with the disease, according to an article on genetic testing in the American Journal of Nursing.

What will the test tell me?

The test will tell you only whether you've inherited any mutations in your BRCA genes. Some mutations are known to be dangerous, some are harmless, and some have unknown effects. How a particular mutation influences your risk for getting breast cancer depends on what other risk factors you may already have (The New York study also suggests that your risk is influenced by environmental factors). For example, if you have a BRCA mutation and know at least one person in your family with a BRCA mutation who has had breast cancer, by the time you are 80 years old, your risk of developing breast cancer will be 82 percent, according to the New York Breast Cancer study. Certain mutations can also raise your risk of ovarian cancer if you have a family history of the disease. A genetic counselor can help you interpret the results of your test.

How do I get tested?

It's important to talk to a counselor first. During your visit, the counselor will ask you about your family medical history and help you determine whether you would benefit from a genetic test. If you opt for a full sequencing of both BRCA genes to check for any mutation that could occur in either gene, it will cost you about $2,400. However, if you are Jewish, it's possible to get tested for the three most common BRCA mutations even if a relative with breast cancer isn't tested, and tests for these common mutations will cost much less (an estimated $650, including genetic counseling).

For either type of test, you'll have a small amount of blood drawn. Your blood will be sent to the laboratory, where technicians will extract DNA from your blood cells and run the test you chose. Depending on the lab and the type of test, it can take from several weeks to several months to get the results, according to the National Cancer Institute. The information will be mailed to your doctor or counselor, who will explain the results to you and help you figure out what you need to do next.

Does a negative result mean I'm free and clear?

Unfortunately, no. Recent studies suggest that the two BRCA genes together account for only 40 to 50 percent of hereditary breast cancer. (Previous estimates pegged them as culprits 90 percent of the time.) That means there are other cancer-related genes out there that the current test doesn't see.

In addition, although breast cancer does tend to run in families, researchers believe that only a minority of cases -- about 5 to 10 percent -- are due to known BRCA genetic mutations. That means that 90 to 95 percent of new cases of breast cancer are unrelated to the genetic changes that can be discovered in tests. About 70 percent of women who develop breast cancer don't have any known relatives with the disease. Most cancers develop because of mutations acquired during your lifetime, due to things like years of exposure to ultraviolet rays and occasional random mistakes that slip by your cells' DNA repair machinery.

What can I do if it turns out I do have a mutation?

Increasing your vigilance could certainly help. Ask your doctor how often you should be getting mammograms and clinical breast exams. (If you've inherited a mutation that increases your risk for ovarian cancer, ask about getting a transvaginal ultrasound screening at least once a year, along with other blood tests. Your doctor might suggest taking the drug tamoxifen , which has been shown to cut breast cancer incidence in half in clinical trials.

For women with true BRCA mutations, some doctors recommend bilateral prophylactic mastectomies -- that is, the removal of both healthy breasts as a precaution. Surgeons can't remove every cell that could potentially become cancerous, however. This operation may decrease your risk by more than 90 percent, but that still leaves you with a 10 percent risk after undergoing surgery.

There is also increasing evidence that removing healthy ovaries (prophylactic oophorectomy) decreases the risk of breast cancer by up to 50 percent.

Another downside to genetic testing: some women have had their insurance rates raised or their coverage dropped after they had a test, regardless of the result. Currently, 39 states have regulations about how genetic information can be used, but there are loopholes. You might consider paying for the test yourself, which would protect your privacy. However, if you start a new health or life insurance policy, you may be asked if you've ever had genetic testing done.

How can I find a qualified genetic counselor?

Look for someone who has seen a large number of women at risk for breast cancer. You'll probably need several hours to discuss your situation, both before and after the test. To find a genetic counselor in your area, call the National Society of Genetic Counselors at (312) 321-6834 or visit their Web site http://www.nsgc.org .

-- Deepi Brar is the multimedia editor at Consumer Health Interactive and a former research scientist in biology. She has published in the medical journal Cancer Gene Therapy, among others.



References


Genetic testing for breast cancer risk: What does it mean to me? American Family Physician, January 1, 1999.

Genetic testing raises questions. American Cancer Society's online Cancer Resource Center; www.cancer.org.

Genetic testing for breast cancer: What are the advantages and disadvantages? National Cancer Institute/CancerNet, 2001.

Yale cancer study underscores fears of discrimination over genetic testing. Yale Cancer Center, 1999.

Population-based study of risk of breast cancer in carriers of BRCA2 mutation. The Lancet, October 24, 1998.

Lucas BD, et al. Genetic testing: What it means today. Patient Care, December 15, 1998.

Levy-Lahad E, et al. A Risky Business: Assessing Breast Cancer Risk. Science: 24 October 2003, Vol. 302.

Genetic Testing for BRCA1 and BRCA2: It's Your Choice. Cancer Facts. National Cancer Institute. Date reviewed: February 6, 2002.

Genomics and Disease Prevention: Fact Sheet on Genetic Testing for Breast and Ovarian Cancer Susceptibility. Centers for Disease Control and Prevention. www.cdc.gov

Mincey BA. Genetics and the management of women at high risk for breast cancer. The Oncologist. 2003;8:466-473

Genetic susceptibility to breast and ovarian cancer: assessment, counseling, and testing guidelines. American College of Medical Genetics Foundation. http://www.health.state.ny.us/nysdoh/cancer/obcancer/contents.htm

Pasacreta JV et al. Genetic testing for breast and ovarian cancer risk: the psychosocial issues. American Journal of Nursing. December 2002. Volume 102 No. 12.

Breast and ovarian cancer genetic screening. Health Maintenance Guidelines. Palo Alto Medical Foundation. http://www.pamf.org/health/guidelines/geneticscreening.html

Genetic Counseling. Lynn Sage Breast Cancer Program/Northwestern University. http://www.lynnsage.northwestern.edu/site/template/info_gen_cou.html

Cost-effectiveness of the identification of women at high risk for the development of breast and ovarian cancer. Massachusetts General Hospital/Harvard University. http://cancer.mgh.harvard.edu/cost05.htm

Do we know what causes breast cancer? Cancer Reference Information, American Cancer Society. http://www.cancer.org/docroot/CRI/content/CRI_2_4_2X_Do_we_know_what_causes_breast_cancer_5.asp?sitearea=CRI&viewmode=print&

Gene abnormalities. Merck Manual: Second Home Edition. http://www.merck.com/mrkshared/mmanual_home2/sec01/ch002/ch002b.jsp

Learning about breast cancer. National Human Genome Research Institute. National Institutes of Health. http://www.genome.gov/page.cfm?pageID=10000507#q2

Are breast and ovarian cancer in your genes? Scripps Health. October 1, 2002. http://www.scrippshealth.org/scrippsnews_1282.asp

Rebbeck TR, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. New England Journal of Medicine. May 23, 2002. 346:1616-1622.

State genetic nondiscrimination in health insurance laws. National Conference of State Legislatures. http://www.ncsl.org/programs/health/genetics/ndishlth.htm

National Human Genome Research Institute. Learning About Breast Cancer. July 2006. http://www.genome.gov/10000507

National Guideline Clearinghouse. Prophylactic Oophorectomy. November 2006. http://www.guideline.gov/summary/summary.aspx?ss=15&doc_id=3958&nbr=3095

Mayo Clinic. Prophylactic oophorectomy: Removing your ovaries to reduce your risk of breast and ovarian cancer. March 2005. http://www.mayoclinic.com/health/breast-cancer/WO00095



Reviewed by Jocelyn J. Dunn, MD, a specialist in breast surgery in private practice in Palo Alto, California.


Our reviewers are members of Consumer Health Interactive's medical advisory board.
To learn more about our writers and editors, click here.

First published July 15, 1999
Last updated January 14, 2008
Copyright © 1999 Consumer Health Interactive


Find more on: 

Back to top of page


Home | Who We Are | Editorial Guidelines | Contact Us | FAQ | Registration | Privacy

All contents copyright ©2005 - Capital District Physicians’ Health Plan, Inc. All rights reserved. CDPHP makes this Web site available free to users for the sole purposes of providing educational information on health-related issues and providing access to health-related resources. This Web site's health-related information and resources are not intended to be a substitute for professional medical advice or for the care that patients receive from their physicians. Please review the Terms of Use before using this Web site. Your use of this Web site indicates your agreement to be bound by the Terms of Use.


We subscribe to the HONcode principles of the Health On the Net Foundation
We subscribe to the HONcode principles. Verify here.
URAC Health Web Site Accreditation Seal Editorial Team Medical Review Board
Medical Review Board and Editorial Team